| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |